InsidersTradesSigma
Follow the 삼성제약 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 삼성제약 has recorded 19 reports. The latest transaction was disclosed on 8 January 2026 (Other). Among the most active insiders: 젬백스. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
19 of 19 declarations
Samsung Pharmaceutical is a South Korean company specializing in the health and pharmaceutical sector. It is listed on the KRX.